文献速递免疫规划传染病防控与疫情报告

多种脊髓灰质炎病毒型别共循环的疫情管理策略

Outbreak management strategies for cocirculation of multiple poliovirus types.
PubMed 文献 · Vaccine · 2023-04-28

既往建模研究显示,当前疫情管理策略不太可能阻止许多地区由1型野生脊髓灰质炎病毒(WPV1)或循环疫苗衍生脊髓灰质炎病毒(cVDPV)引起的疫情,并提示多种脊髓灰质炎病毒型别共循环时疫情风险增加。自2019年开始并持续至今的2型脊髓灰质炎病毒传播激增,加上1型和3型预防性补充免疫活动(SIA)减少,导致多个国家出现多种脊髓灰质炎病毒型别共循环。为展示使用不同疫苗选项和疫情活动策略的影响,作者将传播模型应用于一个假设人群,该人群条件与当前同时经历1型和2型cVDPV疫情的人群相似。

要点

  • 使用三价口服脊髓灰质炎疫苗(tOPV)或同时接种所有三型的OPV配方直至一种疫情型别消失,随后使用型别特异性OPV直至剩余疫情型别消失,可预防最多麻痹病例。
  • 先使用tOPV总体预期成本较低,但可能受限于人群接触2型Sabin OPV株的意愿。
  • 在同时使用2型新型OPV(nOPV2)与二价OPV(bOPV,含1型和3型OPV)的策略中,nOPV2与bOPV同时接种成为领先选项,但可行性、物流、型别特异性接种率和共同接种成本等问题仍存在。

核心结论

  • 当使用三价口服脊髓灰质炎疫苗(tOPV)(或同时接种所有三型的OPV配方)直至一种脊髓灰质炎疫情型别消失,随后使用型别特异性OPV直至剩余疫情型别也消失时,可预防最多麻痹病例。
  • 先使用tOPV总体预期成本较低,但该选项可能受限于人群接触2型Sabin OPV株的意愿。
  • 在同时使用2型新型OPV(nOPV2)与二价OPV(bOPV,含1型和3型OPV)的策略中,nOPV2与bOPV同时接种成为领先选项,但可行性、物流、型别特异性接种率和共同接种成本等问题仍存在。

研究设计与样本

  • 应用传播模型于一个假设人群,该人群条件与当前同时经历1型和2型cVDPV疫情的人群相似。

主要发现

  • 使用tOPV(或同时接种所有三型的OPV配方)直至一种脊髓灰质炎疫情型别消失,随后使用型别特异性OPV直至剩余疫情型别也消失,可预防最多麻痹病例。
  • 先使用tOPV总体预期成本较低,但该选项可能受限于人群接触2型Sabin OPV株的意愿。
  • 在同时使用2型nOPV2与bOPV的策略中,nOPV2与bOPV同时接种成为领先选项,但可行性、物流、型别特异性接种率和共同接种成本等问题仍存在。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prior modeling studies showed that current outbreak management strategies are unlikely to stop outbreaks caused by type 1 wild polioviruses (WPV1) or circulating vaccine-derived polioviruses (cVDPVs) in many areas, and suggested increased risks of outbreaks with cocirculation of more than one type of poliovirus. The surge of type 2 poliovirus transmission that began in 2019 and continues to date, in conjunction with decreases in preventive supplemental immunization activities (SIAs) for poliovirus types 1 and 3, has led to the emergence of several countries with cocirculation of more than one type of poliovirus. Response to these emerging cocirculation events is theoretically straightforward, but the different formulations, types, and inventories of oral poliovirus vaccines (OPVs) available for outbreak response present challenging practical questions. In order to demonstrate the implications of using different vaccine options and outbreak campaign strategies, we applied a transmission model to a hypothetical population with conditions similar to populations currently experiencing outbreaks of cVDPVs of both types 1 and 2. Our results suggest prevention of the largest number of paralytic cases occurs when using (1) trivalent OPV (tOPV) (or coadministering OPV formulations for all three types) until one poliovirus outbreak type dies out, followed by (2) using a type-specific OPV until the remaining poliovirus outbreak type also dies out. Using tOPV first offers a lower overall expected cost, but this option may be limited by the willingness to expose populations to type 2 Sabin OPV strains. For strategies that use type 2 novel OPV (nOPV2) concurrently administered with bivalent OPV (bOPV, containing types 1 and 3 OPV) emerges as a leading option, but questions remain about feasibility, logistics, type-specific take rates, and coadministration costs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kalkowska DA, Badizadegan K, Thompson KM, et al. Outbreak management strategies for cocirculation of multiple poliovirus types. Vaccine. 2023. PMID: 37121801. doi:10.1016/j.vaccine.2023.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。